EIF2AK2 and COVID-19: In the gene expression validation experiment for the COVID-19 group, significant differences were viewed between the disease and normal groups for the IFIT3 and IFI27 genes, while no notable distinction was found in the EIF2AK2 gene (Figure 13B).